# OXLUMO

NDC: 71336-1002
Generic name: lumasiran
Labeler / Manufacturer: Alnylam Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20201123

FDA application: NDA214103

## Active ingredients

- LUMASIRAN SODIUM: 94.5 mg/.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71336-1002"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71336-1002
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=16985a31-f5e4-4557-9266-fc78d4bc5055